Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent, Recurrent, or Metastatic Cervical Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Study completedNCT03635567
What this trial is testing

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 617
Large-scale testing (Phase 3)Enrolling By InvitationNCT06755515
What this trial is testing

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD 510
Large-scale testing (Phase 3)Active Not RecruitingNCT04982237
What this trial is testing

AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Akeso 445
Testing effectiveness (Phase 2)Looking for participantsNCT05817214
What this trial is testing

Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer

Who this might be right for
Cervical Cancer
Zhongnan Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT03367871
What this trial is testing

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami 17
Large-scale testing (Phase 3)Looking for participantsNCT06459687
What this trial is testing

Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Lee's Pharmaceutical Limited 440
Testing effectiveness (Phase 2)Study completedNCT00248560
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute 36
Testing effectiveness (Phase 2)UnknownNCT04395612
What this trial is testing

Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03614949
What this trial is testing

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerCervical Cancer RecurrentCervical Cancer Metastatic
H. Lee Moffitt Cancer Center and Research Institute 21
Large-scale testing (Phase 3)Looking for participantsNCT05798819
What this trial is testing

GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Persistent, Recurrent, or Metastatic Cervical Cancer
Guangzhou Gloria Biosciences Co., Ltd. 424
Testing effectiveness (Phase 2)UnknownNCT02492503
What this trial is testing

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

Who this might be right for
Metastatic Carcinoma to the Uterine CervixRecurrent Carcinoma CervixCervix Carcinoma Recurrent
All India Institute of Medical Sciences 40
Large-scale testing (Phase 3)WithdrawnNCT00057928
What this trial is testing

S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
SWOG Cancer Research Network
Large-scale testing (Phase 3)Ended earlyNCT05179239
What this trial is testing

SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

Who this might be right for
Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 31
Early research (Phase 1)Study completedNCT00004062
What this trial is testing

Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Lucille P. Markey Cancer Center at University of Kentucky
Testing effectiveness (Phase 2)Study completedNCT00430781
What this trial is testing

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Who this might be right for
Neoplasms, Uterine CervixMetastatic Cervical Cancer
GlaxoSmithKline 228
Testing effectiveness (Phase 2)UnknownNCT05824494
What this trial is testing

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Who this might be right for
Uterine Cervical NeoplasmsCancer of CervixCervical Cancer+3 more
Women's Hospital School Of Medicine Zhejiang University 58
Large-scale testing (Phase 3)Looking for participantsNCT07216703
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 1,023